Antiplatelet Therapy in Hemodialysis Patients Undergoing Percutaneous Coronary Interventions

CONTEXT: Coronary artery disease is highly prevalent among patients with end stage renal disease/hemodialysis (ESRD/HD) and coronary percutaneous interventions (PCI) has been increased by nearly 50% over the past decade. After PCI with stent placement, guidelines recommend dual antiplatelet therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Summaria, Francesco, Giannico, Maria B., Talarico, Giovanni P., Patrizi, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4623612/
https://www.ncbi.nlm.nih.gov/pubmed/26528445
http://dx.doi.org/10.5812/numonthly.28099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4623612/
https://www.ncbi.nlm.nih.gov/pubmed/26528445
http://dx.doi.org/10.5812/numonthly.28099

Ejemplares similares